4 studies found for:    L19-SIP
Show Display Options
Rank Status Study
1 Completed 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
Condition: Brain Metastases From Solid Tumors
Intervention: Radiation: 131I-L19SIP Radioimmunotherapy (RIT) in Combination With Whole Brain Radiation Therapy (WBRT)
2 Terminated 131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)
Condition: Non Small Cell Lung Cancer
Intervention: Other: 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiotherapy (EBRT) and Concurrent Chemotherapy
3 Terminated Radioimmunotherapy With 131I-L19SIP in Patients With Cancer
Condition: Patients With Cancer
Intervention: Drug: 131I-L19SIP Radioimmunotherapy (RIT)
4 Completed A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer
Condition: Cancer
Intervention: Drug: 131I-F16SIP Radioimmunotherapy (RIT)

Indicates status has not been verified in more than two years